Article info
PDFResearch ethics
Participant selection for preventive Regenerative Medicine trials: ethical challenges of selecting individuals at risk
- Correspondence to Dr Michelle G J L Habets, Department of Medical Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, P.O. Box 85060, Utrecht 3508 AB, The Netherlands; m.g.j.habets{at}umcutrecht.nl
Citation
Participant selection for preventive Regenerative Medicine trials: ethical challenges of selecting individuals at risk
Publication history
- Received December 3, 2014
- Revised April 16, 2015
- Accepted August 17, 2015
- First published September 4, 2015.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Adipose derived mesenchymal stem cell therapy in the treatment of isolated knee chondral lesions: design of a randomised controlled pilot study comparing arthroscopic microfracture versus arthroscopic microfracture combined with postoperative mesenchymal stem cell injections
- Patellofemoral osteoarthritis coexistent with tibiofemoral osteoarthritis in a meniscectomy population
- Autologous stem cell therapy in knee osteoarthritis: a systematic review of randomised controlled trials
- ARTIST (osteoarthritis intervention standardized) study of standardised consultation versus usual care for patients with osteoarthritis of the knee in primary care in France: pragmatic randomised controlled trial
- Finnish Degenerative Meniscal Lesion Study (FIDELITY): a protocol for a randomised, placebo surgery controlled trial on the efficacy of arthroscopic partial meniscectomy for patients with degenerative meniscus injury with a novel ‘RCT within-a-cohort’ study design
- Early knee osteoarthritis
- Change in self-reported outcomes and objective physical function over 7 years in middle-aged subjects with or at high risk of knee osteoarthritis
- Patient reported outcomes in patients undergoing arthroscopic partial meniscectomy for traumatic or degenerative meniscal tears: comparative prospective cohort study
- Degenerative meniscus tears - assimilation of evidence and consensus statements across three continents: state of the art
- Arthroscopic partial meniscectomy for a degenerative meniscus tear: a 5 year follow-up of the placebo-surgery controlled FIDELITY (Finnish Degenerative Meniscus Lesion Study) trial